HU194893B - Process for producing cristalline sodium salt of d-6-brace alpha-(/2-oxo-3-furfuriliden-amino-imidazolidin-1-yl/-carbonyl-amino)-thienyl-2-acetamido-brace closed-penicillanic acid and pharmaceutical compositions containing them - Google Patents
Process for producing cristalline sodium salt of d-6-brace alpha-(/2-oxo-3-furfuriliden-amino-imidazolidin-1-yl/-carbonyl-amino)-thienyl-2-acetamido-brace closed-penicillanic acid and pharmaceutical compositions containing them Download PDFInfo
- Publication number
- HU194893B HU194893B HU853216A HU321685A HU194893B HU 194893 B HU194893 B HU 194893B HU 853216 A HU853216 A HU 853216A HU 321685 A HU321685 A HU 321685A HU 194893 B HU194893 B HU 194893B
- Authority
- HU
- Hungary
- Prior art keywords
- amino
- sodium salt
- brace
- acid
- water
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
- C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
- C07D499/58—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
- C07D499/64—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms
- C07D499/70—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms with hetero rings as additional substituents on the carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843431273 DE3431273A1 (de) | 1984-08-25 | 1984-08-25 | Kristallines natriumsalz der d-6-((alpha)-(2-oxo-3-furfuryl-iden-amino-imidazolidin-1-yl)-carbonylamino)-thienyl-2-acetamido)-penicillansaeure, verfahren zur herstellung und seine verwendung in arzneimitteln |
| CN85106479A CN85106479B (zh) | 1984-08-25 | 1985-08-29 | 晶状的右旋-6-{α-[(2-氧代-3-亚糠基-氨基-咪唑烷-1-基)碳酰氨基]-2-噻吩基乙酰氨基}-青霉烷酸钠盐制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUT38354A HUT38354A (en) | 1986-05-28 |
| HU194893B true HU194893B (en) | 1988-03-28 |
Family
ID=25741999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU853216A HU194893B (en) | 1984-08-25 | 1985-08-23 | Process for producing cristalline sodium salt of d-6-brace alpha-(/2-oxo-3-furfuriliden-amino-imidazolidin-1-yl/-carbonyl-amino)-thienyl-2-acetamido-brace closed-penicillanic acid and pharmaceutical compositions containing them |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0176716B1 (OSRAM) |
| JP (1) | JPS6157589A (OSRAM) |
| KR (1) | KR860001818A (OSRAM) |
| CN (1) | CN85106479B (OSRAM) |
| AT (1) | ATE34576T1 (OSRAM) |
| AU (1) | AU559040B2 (OSRAM) |
| DE (2) | DE3431273A1 (OSRAM) |
| DK (1) | DK385085A (OSRAM) |
| ES (1) | ES8609340A1 (OSRAM) |
| FI (1) | FI853211L (OSRAM) |
| GR (1) | GR852047B (OSRAM) |
| HU (1) | HU194893B (OSRAM) |
| IL (1) | IL76164A0 (OSRAM) |
| NO (1) | NO853188L (OSRAM) |
| NZ (1) | NZ213198A (OSRAM) |
| PH (1) | PH21842A (OSRAM) |
| PT (1) | PT81014B (OSRAM) |
| ZA (1) | ZA856413B (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW347383B (en) * | 1995-10-26 | 1998-12-11 | Biochemie Gmbh | A process for the production of a crystalline sodium salt of amoxicillin in ethanol as solvent |
| US9844374B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL85039B1 (pl) * | 1972-02-17 | 1977-02-26 | Tarchomińskie Zakłady Farmaceutyczne | Sposób wytwarzania soli sodowej a-ftminobenzylopeiiicylmy |
| PL87153B1 (pl) * | 1973-07-13 | 1976-12-15 | Tarchomińskie Zakłady Farmaceutyczne | Sposób otrzymywania krystalicznej soli dwusodowej penicyliny a-karboksybenzylowej |
| DE2732283A1 (de) * | 1977-07-16 | 1979-01-25 | Bayer Ag | Beta-lactam-verbindungen |
| DE2732323A1 (de) * | 1977-07-16 | 1979-01-25 | Bayer Ag | Beta-lactam-verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung |
| JPS5940727A (ja) * | 1982-07-28 | 1984-03-06 | Fujitsu Ltd | 自動等化方式 |
-
1984
- 1984-08-25 DE DE19843431273 patent/DE3431273A1/de not_active Withdrawn
-
1985
- 1985-08-13 NO NO853188A patent/NO853188L/no unknown
- 1985-08-14 EP EP85110189A patent/EP0176716B1/de not_active Expired
- 1985-08-14 AT AT85110189T patent/ATE34576T1/de active
- 1985-08-14 DE DE8585110189T patent/DE3562918D1/de not_active Expired
- 1985-08-21 FI FI853211A patent/FI853211L/fi not_active Application Discontinuation
- 1985-08-22 NZ NZ213198A patent/NZ213198A/xx unknown
- 1985-08-22 IL IL76164A patent/IL76164A0/xx unknown
- 1985-08-22 AU AU46577/85A patent/AU559040B2/en not_active Ceased
- 1985-08-23 JP JP60185652A patent/JPS6157589A/ja active Pending
- 1985-08-23 ZA ZA856413A patent/ZA856413B/xx unknown
- 1985-08-23 HU HU853216A patent/HU194893B/hu not_active IP Right Cessation
- 1985-08-23 GR GR852047A patent/GR852047B/el unknown
- 1985-08-23 ES ES546379A patent/ES8609340A1/es not_active Expired
- 1985-08-23 DK DK385085A patent/DK385085A/da not_active Application Discontinuation
- 1985-08-23 PT PT81014A patent/PT81014B/pt not_active IP Right Cessation
- 1985-08-23 PH PH32687A patent/PH21842A/en unknown
- 1985-08-24 KR KR1019850006132A patent/KR860001818A/ko not_active Abandoned
- 1985-08-29 CN CN85106479A patent/CN85106479B/zh not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IL76164A0 (en) | 1985-12-31 |
| HUT38354A (en) | 1986-05-28 |
| ATE34576T1 (de) | 1988-06-15 |
| DE3562918D1 (en) | 1988-06-30 |
| ES546379A0 (es) | 1986-07-16 |
| NO853188L (no) | 1986-02-26 |
| FI853211A0 (fi) | 1985-08-21 |
| EP0176716B1 (de) | 1988-05-25 |
| PH21842A (en) | 1988-03-17 |
| CN85106479A (zh) | 1987-03-18 |
| PT81014A (en) | 1985-09-01 |
| KR860001818A (ko) | 1986-03-22 |
| EP0176716A1 (de) | 1986-04-09 |
| FI853211A7 (fi) | 1986-02-26 |
| JPS6157589A (ja) | 1986-03-24 |
| NZ213198A (en) | 1989-02-24 |
| AU4657785A (en) | 1986-02-27 |
| PT81014B (pt) | 1987-12-30 |
| DE3431273A1 (de) | 1986-03-06 |
| AU559040B2 (en) | 1987-02-19 |
| DK385085A (da) | 1986-02-26 |
| DK385085D0 (da) | 1985-08-23 |
| ZA856413B (en) | 1986-04-30 |
| CN85106479B (zh) | 1988-07-27 |
| ES8609340A1 (es) | 1986-07-16 |
| FI853211L (fi) | 1986-02-26 |
| GR852047B (OSRAM) | 1985-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5354760A (en) | Crystalline Tiagabine monohydrate, its preparation and use | |
| BG65027B1 (bg) | Полиморфни форми на телмизартан, метод за тяхнотополучаване и тяхната употреба за получаване на лекарство | |
| JP4590038B2 (ja) | エナンチオマー的に純粋なイミダゾリル化合物の製造方法 | |
| US5034541A (en) | Method of preparing 1-phenyl-1-diethylaminocarbonyl-2-phthalimidomethyl-cyclopropane-z | |
| HU180430B (en) | Process for preparing substituted 2-phenyl-imino-imidazolidines and acid addition salts thereof infulencing the cardiovascular system | |
| US6844449B2 (en) | Modifications of the trometamol salt of R-thioctic acid as well as a process for their production | |
| EP3981759B1 (en) | New crystal form of treprostinil sodium salt and preparation method therefor | |
| US4775673A (en) | Substituted acylpiperazinoquinazolines and pharmaceutical compositions containing same | |
| RU2228931C2 (ru) | Кристаллические формы 3-(2,4-дихлорбензил)-2-метил-n-(пентилсульфонил)-3h- бензимидазол-5-карбоксамида | |
| US6538012B2 (en) | Amlodipine hemimaleate | |
| JP2002526498A (ja) | ナフチリジンカルボン酸誘導体（メタンスルホネート・セスキ水和物）の製法 | |
| CA2239313C (en) | Solid compound, its preparation and use in medicine | |
| CA2389170C (en) | A process for the production of epinastine hydrochloride in the high-melting crystal modification | |
| JP2002517398A (ja) | アモキシシリンの結晶性塩の製造方法 | |
| US6828438B2 (en) | Process for the preparation of the sodium salt of 6[D-(-)α-4-(ethyl-2,3-dioxo-1-piperazinocarbonylamino)phenylacetamido]penicillanic acid | |
| JP2001502663A (ja) | 置換バリンアミド誘導体の製造方法 | |
| JPH11515011A (ja) | アモキシリンの結晶塩の製造法 | |
| NO853188L (no) | Krystallinsk natriumsalt av d-6-(d-((2-okso-3-furfuryli-den-amino-imidazolidin-1-yl)karbonyl-amino)-tienyl-2-acet-amido)-penicillansyre, fremgangsmaate til dens fremstilling og dens anvendelse i legemidler. | |
| HU176213B (en) | Process for preparing a new crystallic modification of the sodium salt of 7beta-cyanacetylamino-3-acetoxymethyl-cef-3-em-4-carboxylic acid | |
| KR100199066B1 (ko) | 26-(디알킬아미노알킬설포닐)프리스티나마이신 iib로 부터 유도되는 신규한 염 | |
| KR100917593B1 (ko) | 덱시부프로펜염의 제조방법 | |
| KR20010006117A (ko) | 단일 에난티오머 나웨딘을 제조하기 위한 방법 | |
| US4439363A (en) | Acetylmethyl ester of hetacyllin and/or salts of this ester | |
| JP3001975B2 (ja) | 結晶性チアガビン塩酸塩−水和物、その製造方法および用途 | |
| HK40067809A (en) | New crystal form of treprostinil sodium salt and preparation method therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HU90 | Patent valid on 900628 | ||
| HMM4 | Cancellation of final prot. due to non-payment of fee |